Auriga raises its price target on Buy-rated Universal Health Services UHS to $51 from $45 on in-line Q4 and likely conservative 2012 guidance.
Auriga notes, "UHS issued EPS guidance range to $4.33-$4.48 (v. consensus $4.42) on revenue increase of +5% to $7.24B. Note that revenue guidance includes adoption of ASU No. 2011-7. We believe EPS guidance may prove to be conservative if economic activity continues to improve nationally and picks up in Las Vegas."
UHS closed at $43.97 a share yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in